Skip to main content
Fig. 3 | BMC Immunology

Fig. 3

From: Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma

Fig. 3

ROC curve analysis for serum sCTLA-4 concentration. a The most discriminative cutoff value for sCTLA-4 for glioma was 112.1 pg/ml with an AUC value of 0.880 (95% confidence interval: 0.816 to 0.943, p < 0.05). The sensitivity and specificity were 82.0 and 78.0%, respectively. b A cut-off value of 220.43 pg/ml was best distinguished in patients between low-grade glioma group and high-grade glioma group with sensitivity73.1% and specificity 79.2% (95% confidence interval: 0.619 to 0.894, p < 0.05). sCTLA-4, soluble cytotoxic T-lymphocyte antigen 4

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us